Market Snapshot

BSE Sensex: 83576.24 -0.72%
BSE 500: 36807.62 -0.89%
BSE 200: 11620.53 -0.79%
BSE 100: 26904.82 -0.73%
BSE MidCap: 46304.8 -0.90%
BSE SmallCap: 49912.11 -1.74%
BSE BANKEX: 66616.92 -0.58%
BSE IT: 36795.24 0.03%
Nifty 50: 25683.3 -0.75%
Nifty 500: 23467.35 -0.90%
Nifty 200: 14306.95 -0.79%
Nifty 100: 26252.95 -0.79%
Nifty Midcap 100: 59748.15 -0.79%
Nifty Small 100: 17282.65 -1.81%
Nifty IT: 38027.2 0.28%
Nifty PSU Bank: 8601.05 0.18%

News:

Protean eGov Technologies bags...
PTC Industries? arm secures ma...
Globus Spirits reports multi-f...
IREDA Q3 PAT jumps 15% YoY to ...
Tejas Networks reports dismal ...

Fermenta Biotech Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

09 Jan 2026 | 03:59 PM

328.00

-8.30 (-2.47%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-21.19%

Return (1Y)

Underperformed BSE Healthcare by 18.74%
More Volatile

3.42%

Standard Deviation (1Y)

Higher than BSE Healthcare by 2.46%
Not so consistent

6/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

449

219

News & Announcements

Fermenta Biotech announces board meeting date
35 days ago

Fermenta Biotech announces board meeting date

08 - Dec - 2025 12:00 | 35 days ago

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 10 December 2025.
Powered by Capital Market - Live News
Fermenta Biotech consolidated net profit rises 65.91% in the September 2025 quarter
61 days ago

Fermenta Biotech consolidated net profit rises 65.91% in the September 2025 quarter

12 - Nov - 2025 12:00 | 61 days ago

Net profit of Fermenta Biotech rose 65.91% to Rs 18.88 crore in the quarter ended September 2025 as against Rs 11.38 crore during the previous quarter ended September 2024. Sales rose 37.03% to Rs 130.22 crore in the quarter ended September 2025 as against Rs 95.03 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 130.22 95.03 37

OPM % 20.46 19.76 -

PBDT 29.49 17.97 64

PBT 24.08 11.82 104

NP 18.88 11.38 66

Powered by Capital Market - Live News
Fermenta Biotech schedules board meeting
74 days ago

Fermenta Biotech schedules board meeting

30 - Oct - 2025 12:00 | 74 days ago

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2025.
Powered by Capital Market - Live News
Fermenta Biotech receives Indian patent for its plant-based Vitamin D3
122 days ago

Fermenta Biotech receives Indian patent for its plant-based Vitamin D3

12 - Sep - 2025 12:00 | 122 days ago

Fermenta Biotech announced that the Indian Patent Office has formally granted a patent for its invention of a plant-based Vitamin D3.

Fermenta's newly granted patent safeguards its proprietary process for producing plant based Vitamin D3, marking a significant advancement in its innovation pipeline and reinforcing its leadership in the global Vitamin D3 domain. This market-leading vegan solution responds to the accelerating global demand for ethically sourced, sustainable nutrition and positions Fermenta at the forefront of the plant-based nutrition revolution. By enabling the production of completely vegan and vegetarian-friendly Vitamin D3, the invention captures emerging opportunities across nutraceutical and food fortification sectors, where sustainable, plant-derived ingredients command premiums and growing market share.

Prashant Nagre, Managing Director of Fermenta, said: ?The grant of this patent is a proud milestone in our journey of innovation. It reflects our dedication to addressing evolving consumer needs with environmentally conscious solutions. Plant-based Vitamin D3 represents the future of nutrition, and this patent reinforces our ability to deliver differentiated offerings that create long-lasting impact for both our partners and society at large. It also strengthens India's role as a hub for pioneering industrial innovation, showcasing how local science can contribute to global wellness.?
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in DIL Ltd has decreased by -51.37% since past 1 Year
Promoter shareholding in DIL Ltd has increased by 3.26% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	130.22	95.03	37
OPM %	20.46	19.76	-
PBDT	29.49	17.97	64
PBT	24.08	11.82	104
NP	18.88	11.38	66

General Notifications

My Notifications

Research Notifications

Fermenta Biotech Ltd Share Price – BSE Pharmaceuticals, Small Cap

328.00 -8.30 (-2.47%)

News & Announcements

Price vs Volume

Stock Trivia

Fermenta Biotech Ltd Share Price – BSE
Pharmaceuticals, Small Cap

328.00

-8.30 (-2.47%)